HopeStage
Back to all studies
Enrolling By InvitationNCT07198711

Induction of Dreaming With EEG and Anesthesia in Healthy Adults

Medication studyAges 18–70United StatesDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 70 years.

Listed locations
StanfordSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 20, 2025
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
15
Sponsor
Stanford University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT07198711
Official title
Show the full official title

Comparison of Ketamine Versus Saline During Sedation in Patients With Major Depressive Disorder: a Double-blind Trial

Recruitment & locations

By invitation

Stanford

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Stanford University, a university.

Does this study involve medication?

Yes. The study involves medication, including Propofol - Emergence-from-LOR Protocol and Propofol - Light Sedation Protocol.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as enrolling by invitation.

Want to explore more studies?

Explore studies